home / stock / rspid / rspid quote
Last: | $0.034 |
---|---|
Change Percent: | 1.8% |
Open: | $0.03555 |
Close: | $0.034 |
High: | $0.0356 |
Low: | $0.0302 |
Volume: | 722,921 |
Last Trade Date Time: | 02/03/2021 04:55:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.034 | $0.03555 | $0.034 | $0.0356 | $0.0302 | 722,921 | 02-03-2021 |
$0.0334 | $0.034 | $0.0334 | $0.0362 | $0.0325 | 1,009,655 | 02-02-2021 |
$0.034 | $0.03425 | $0.034 | $0.04 | $0.03 | 203,311 | 02-01-2021 |
$0.035 | $0.038 | $0.035 | $0.04 | $0.0325 | 605,398 | 01-29-2021 |
$0.032 | $0.035 | $0.032 | $0.0415 | $0.03 | 876,515 | 01-28-2021 |
$0.032 | $0.0328 | $0.032 | $0.035 | $0.0306 | 822,254 | 01-27-2021 |
$0.0328 | $0.03 | $0.0328 | $0.0376 | $0.03 | 575,399 | 01-26-2021 |
$0.0377 | $0.03875 | $0.0377 | $0.0388 | $0.0315 | 406,572 | 01-25-2021 |
$0.032 | $0.033 | $0.032 | $0.036 | $0.0313 | 491,927 | 01-22-2021 |
$0.033 | $0.04085 | $0.033 | $0.0411 | $0.0312 | 735,444 | 01-21-2021 |
$0.034 | $0.0306 | $0.034 | $0.041 | $0.0275 | 1,042,329 | 01-20-2021 |
$0.0311 | $0.04445 | $0.0311 | $0.0445 | $0.0311 | 1,262,383 | 01-19-2021 |
$0.0346 | $0.0345 | $0.0346 | $0.0425 | $0.0302 | 2,384,425 | 01-18-2021 |
$0.0346 | $0.0345 | $0.0346 | $0.0425 | $0.0302 | 2,384,425 | 01-15-2021 |
$0.0388 | $0.0256 | $0.0388 | $0.0388 | $0.0256 | 994,814 | 01-14-2021 |
$0.026 | $0.03045 | $0.026 | $0.032 | $0.0256 | 617,370 | 01-13-2021 |
$0.0289 | $0.0285 | $0.0289 | $0.033 | $0.0268 | 657,468 | 01-12-2021 |
$0.0265 | $0.026 | $0.0265 | $0.029 | $0.0246 | 712,022 | 01-11-2021 |
$0.0231 | $0.02375 | $0.0231 | $0.0265 | $0.0231 | 1,507,272 | 01-08-2021 |
$0.0249 | $0.0285 | $0.0249 | $0.03 | $0.023 | 1,758,332 | 01-07-2021 |
News, Short Squeeze, Breakout and More Instantly...
RespireRx Pharmaceuticals Company Name:
RSPID Stock Symbol:
OTCMKTS Market:
Glen Rock, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB Market: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of ...
Glen Rock, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal...
Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuron...